Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced, that the US Food and Drug Administration (FDA) approved Aklief (trifarotene) cream, 0.005% for the topical
Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced, that the US Food and Drug Administration (FDA) approved Aklief (trifarotene) cream, 0.005% for the topical
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
